메뉴 건너뛰기




Volumn 24, Issue 1, 2005, Pages 60-63

Discovery and taking care of an haemorrhagic urgency revealing an acquired haemophilia;Découverte et prise en charge d'une urgence hémorragique révélatrice d'une hémophilie acquise

Author keywords

Acquired haemophilia; Autoantibody antifacteur VIII; Autoanticorps antifacteur VIII; H mophilie acquise; Post partum; Postpartum

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HEALTH CARE; HEMOPHILIA; HISTORY OF MEDICINE; HUMAN; OVARIAN BLEEDING; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PREGNANCY; THROMBOPLASTIN TIME;

EID: 12444279959     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2004.11.007     Document Type: Article
Times cited : (4)

References (22)
  • 1
    • 0001690740 scopus 로고
    • Hemorrhagic diathesis with prolonged coagulation time associated with a circulating anticoagulant
    • E.L. Lozier, L.S. Jolliffe, and F.H.L. Taylor Hemorrhagic diathesis with prolonged coagulation time associated with a circulating anticoagulant Am. J. Med. Sci. 199 1940 318 327
    • (1940) Am. J. Med. Sci. , vol.199 , pp. 318-327
    • Lozier, E.L.1    Jolliffe, L.S.2    Taylor, F.H.L.3
  • 2
    • 85047693150 scopus 로고
    • A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy
    • R. Lottenberg, T.B. Kentro, and C.S. Kitchens A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy Arch. Intern. Med. 147 1987 1077 1081
    • (1987) Arch. Intern. Med. , vol.147 , pp. 1077-1081
    • Lottenberg, R.1    Kentro, T.B.2    Kitchens, C.S.3
  • 4
    • 0001242335 scopus 로고
    • An acquired haemorrhagicdisease in a female due to an inhibitor of blood coagulation
    • P. Fantl, and M.H. Nance An acquired haemorrhagicdisease in a female due to an inhibitor of blood coagulation Med. J. Austr. 2 1946 125 129
    • (1946) Med. J. Austr. , vol.2 , pp. 125-129
    • Fantl, P.1    Nance, M.H.2
  • 5
    • 0006895933 scopus 로고
    • Haemorrhagic diathesis associated with low thromboplastic activity and circulating anticoagulant
    • R.W. Heinle, A.S. Weisberger, and P.J. Vignos Haemorrhagic diathesis associated with low thromboplastic activity and circulating anticoagulant J. Lab. Clin. Med. 34 1949 1606 1610
    • (1949) J. Lab. Clin. Med. , vol.34 , pp. 1606-1610
    • Heinle, R.W.1    Weisberger, A.S.2    Vignos, P.J.3
  • 6
    • 0029948962 scopus 로고    scopus 로고
    • Combinated treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitors
    • M. Jose-Aguado, V. Carrasco, A. Periago, T. Bello, E. Gonzalez, and J. Garcia-Talavera Combinated treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitors Sangre (Barc.) 41 1996 147 150
    • (1996) Sangre (Barc.) , vol.41 , pp. 147-150
    • Jose-Aguado, M.1    Carrasco, V.2    Periago, A.3    Bello, T.4    Gonzalez, E.5    Garcia-Talavera, J.6
  • 8
    • 0030700329 scopus 로고    scopus 로고
    • The treatment of bleeding in acquired haemophilia with recombinant factor VIIa
    • C.R.M. Hay, C. Negrier, and C.A. Ludlam The treatment of bleeding in acquired haemophilia with recombinant factor VIIa Thromb. Haemost. 78 1997 1463 1467
    • (1997) Thromb. Haemost. , vol.78 , pp. 1463-1467
    • Hay, C.R.M.1    Negrier, C.2    Ludlam, C.A.3
  • 9
    • 0019501541 scopus 로고
    • A survey of 215 non-hemophilic patients with inhibitors to factor VIII
    • D. Green, and K. Lechner A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb. Haemost. 45 1981 200 203
    • (1981) Thromb. Haemost. , vol.45 , pp. 200-203
    • Green, D.1    Lechner, K.2
  • 11
    • 0027379905 scopus 로고
    • A prospective randomised trial of prednisolone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies
    • D. Green, A.W. Rademaker, and E. Briet A prospective randomised trial of prednisolone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies Thromb. Haemost. 70 1993 753 757
    • (1993) Thromb. Haemost. , vol.70 , pp. 753-757
    • Green, D.1    Rademaker, A.W.2    Briet, E.3
  • 12
    • 0019426520 scopus 로고
    • Corticosteroid therapy for acquired factor VIII: C inhibitors
    • J.A. Spero, J.H. Lewis, and U. Hasiba Corticosteroid therapy for acquired factor VIII: C inhibitors Br. J. Haematol. 48 1981 635 642
    • (1981) Br. J. Haematol. , vol.48 , pp. 635-642
    • Spero, J.A.1    Lewis, J.H.2    Hasiba, U.3
  • 13
    • 0029998402 scopus 로고    scopus 로고
    • Recommendations for the treatment of factor VIII inhibitors: From the UK Haemophilia Centre Directors Organisation Inhibitor Working Party
    • C.R. Hay, B.T. Colvin, C.A. Ludlam, F.G. Hill, and F.E. Preston Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors Organisation Inhibitor Working Party Blood Coagul. Fibrinolysis 7 1996 134 138
    • (1996) Blood Coagul. Fibrinolysis , vol.7 , pp. 134-138
    • Hay, C.R.1    Colvin, B.T.2    Ludlam, C.A.3    Hill, F.G.4    Preston, F.E.5
  • 14
    • 0027405692 scopus 로고
    • Use of porcine factor VII in the treatment of patients with acquired hemophilia
    • A.E. Morrison, C.A. Ludlam, and C. Kessler Use of porcine factor VII in the treatment of patients with acquired hemophilia Blood 81 1993 1513 1520
    • (1993) Blood , vol.81 , pp. 1513-1520
    • Morrison, A.E.1    Ludlam, C.A.2    Kessler, C.3
  • 15
    • 0027285439 scopus 로고
    • Comparison of anti-human an anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. a French Multicentric Study
    • M. Fiks-Sigaud, L. Bendelac, A. Parquet, F. Verroust, M.F. Torchet, and A.M. Berthier Comparison of anti-human an anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study Vox Sang. 64 1993 210 214
    • (1993) Vox Sang. , vol.64 , pp. 210-214
    • Fiks-Sigaud, M.1    Bendelac, L.2    Parquet, A.3    Verroust, F.4    Torchet, M.F.5    Berthier, A.M.6
  • 16
    • 0021368359 scopus 로고
    • Clinical experience with polyelctrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII
    • P.B. Kernoff, N.D. Thomas, P.A. Lilley, K.B. Matthews, and E.G. Goldman Etuddenham Clinical experience with polyelctrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII Blood 63 1984 31 41
    • (1984) Blood , vol.63 , pp. 31-41
    • Kernoff, P.B.1    Thomas, N.D.2    Lilley, P.A.3    Matthews, K.B.4    Goldman Etuddenham, E.G.5
  • 17
    • 0032140169 scopus 로고    scopus 로고
    • Le facteur VII recombinant activ́:: Un nouveau traitement de l'h́mophilie
    • J. Goudeman Le facteur VII recombinant activ́:: un nouveau traitement de l'h́mophilie Transfus. Clin. Biol. 5 1998 260 265
    • (1998) Transfus. Clin. Biol. , vol.5 , pp. 260-265
    • Goudeman, J.1
  • 18
    • 0030700329 scopus 로고    scopus 로고
    • The treatment of bleeding in acquired haemophilia with recombinant factor VIIa
    • C.R.M. Hay, C. Negrier, and C.A. Ludlam The treatment of bleeding in acquired haemophilia with recombinant factor VIIa Thromb. Haemost. 78 1997 1463 1467
    • (1997) Thromb. Haemost. , vol.78 , pp. 1463-1467
    • Hay, C.R.M.1    Negrier, C.2    Ludlam, C.A.3
  • 19
    • 0025477245 scopus 로고
    • Factor VII in the treatment of haemophilia
    • U. Hedner Factor VII in the treatment of haemophilia Blood Coagul. Fibrinolysis 1 1990 307 317
    • (1990) Blood Coagul. Fibrinolysis , vol.1 , pp. 307-317
    • Hedner, U.1
  • 20
    • 0027522777 scopus 로고
    • Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders
    • U. Hedner, S. Glazer, and J. Falch Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders Transfus. Med. Rev. 7 1993 78 83
    • (1993) Transfus. Med. Rev. , vol.7 , pp. 78-83
    • Hedner, U.1    Glazer, S.2    Falch, J.3
  • 21
    • 0027236665 scopus 로고
    • Safety and initial efficacy of three dose-levels of recombinant activated factor VII (rVIIa): Results of a phase I study
    • B.G. Macik, C.M. Lindley, J. Lusher, W.T. Sawyer, A.L. Bloom, and J.F. Harrison Safety and initial efficacy of three dose-levels of recombinant activated factor VII (rVIIa): results of a phase I study Blood Coagul. Fibrinolysis 4 1993 521 527
    • (1993) Blood Coagul. Fibrinolysis , vol.4 , pp. 521-527
    • MacIk, B.G.1    Lindley, C.M.2    Lusher, J.3    Sawyer, W.T.4    Bloom, A.L.5    Harrison, J.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.